… vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative
agent of the respiratory disease coronavirus disease 2019 (COVID-19), messenger RNA (…

… The terminology for the RNA virus that causes COVID-19, SARS-CoV-2, has been … homology
with the 2003 SARS coronavirus. The SARS-CoV-2 coronavirus belongs to the subfamily of …

… In conclusion, the SARS-CoV-2 mRNA vaccines were highly effective for preventing Covid-19
hospitalizations among adults in March through May 2021. Widespread vaccination can …

… The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine that …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19. …

… We found that the efficacy of the mRNA-1273 vaccine against Covid-19 and severe Covid-19
was maintained for more than 5 months after the second dose among all subgroups in the …

… with the mRNA vaccine. We found that the Pfizer-BioNTech COVID-19 mRNA vaccine elicits
a … observed in pregnant women with third trimester SARS-CoV-2 infection, as was previously …

… with the mRNA-based Pfizer-BioNTech vaccine and somewhat later the Moderna mRNA and
… In the present report, we show that two-dose vaccination with the BNT162b2 mRNA COVID-…

… -2 at scheduled or unscheduled postbaseline visits without any Covid-19 symptoms in
participants with negative SARS-CoV-2 serologic findings and negative RT-PCR test results at …

… syndrome coronavirus 2 (SARS-CoV-… coronavirus disease 2019 (Covid-19). The urgent
need for vaccines prompted an international response, with more than 120 candidate SARS-CoV…

… COVID-19 mRNA vaccines consists of eliciting high titers of high-affinity antibodies against
Spike proteins and RBDs capable of neutralizing SARS-CoV… /BioNTech COVID-19 mRNA …